Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro

Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro
复制标题

膀胱癌特异性溶瘤腺病毒基因治疗联合顺铂治疗膀胱癌的体外效果

DOI:
10.1007/s13277-014-2353-7
复制
发表时间:
2014-08
期刊:
影响因子:
--
通讯作者:
Wang Zhiping
Wang Zhiping
中科院分区:
--
文献类型:
--
作者:
Xiao Erlong;Lu Jianzhong;Fu Shengjun;Wang Zhiping

文献摘要

参考文献

相似文献

膀胱癌特异性溶瘤腺病毒Ad/PSCAE/UPII/E1A携带受人尿斑蛋白II(UPII)启动子和前列腺干细胞抗原增强子(PSCAE)调控的E1A基因,可以优先杀伤膀胱肿瘤细胞。这项研究的目的是
Bladder cancer-specific oncolytic adenovirus Ad/PSCAE/UPII/E1A, carrying E1A gene regulated by human Uroplakin II (UPII) promoter and prostate stem cell antigen enhancer (PSCAE), could kill bladder tumor cells preferentially. The aim of this study was to
DOI: --
发表时间: 2001-06
期刊: Cancer research
影响因子: 11.2
作者:
X. Peng;J. Won;T. Rutherford;T. Fujii;D. Zelterman;G. Pizzorno;E. Sapi;J. Leavitt;B. Kacinski;R. Crystal;P. Schwartz;A. Deisseroth
通讯作者: X. Peng;J. Won;T. Rutherford;T. Fujii;D. Zelterman;G. Pizzorno;E. Sapi;J. Leavitt;B. Kacinski;R. Crystal;P. Schwartz;A. Deisseroth
DOI: 10.1038/gt.2011.180
发表时间: 2012-11
期刊: Gene therapy
影响因子: 5.1
作者:
通讯作者: --
DOI: 10.4049/jimmunol.148.7.2207
发表时间: 1992-04
影响因子: 4.4
作者:
V. Fadok;D. Voelker;P. Campbell;J. Cohen;D. Bratton;P. Henson
通讯作者: V. Fadok;D. Voelker;P. Campbell;J. Cohen;D. Bratton;P. Henson
DOI: --
发表时间: 1993
期刊: Journal of the National Cancer Institute. Monographs
影响因子: --
作者:
R. Parker;M. Dabholkar;K. B. Lee;F. Bostick-Bruton;E. Reed
通讯作者: R. Parker;M. Dabholkar;K. B. Lee;F. Bostick-Bruton;E. Reed
DOI: --
发表时间: 2006
期刊: Materials Today
影响因子: 24.2
作者:
David;I. Kleinerman;Colin;P. N. Dinney;Wei-Wei-Wei;Zhang;Sue-Hwa;Lin;Nguyen;T. Van;Jer-Tsong;Hsieh
通讯作者: David;I. Kleinerman;Colin;P. N. Dinney;Wei-Wei-Wei;Zhang;Sue-Hwa;Lin;Nguyen;T. Van;Jer-Tsong;Hsieh